<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a patient who had <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="48120">anthracycline</z:chebi>-induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> that was reversed after treatment with a left ventricular assist device </plain></SENT>
<SENT sid="1" pm="."><plain>A 29-year-old woman had undergone <z:chebi fb="0" ids="48120">anthracycline</z:chebi>-based chemotherapy as a teenager in 1991 and 1992 and received a diagnosis of <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> 10 years later </plain></SENT>
<SENT sid="2" pm="."><plain>Optimal medical therapy had initially controlled the symptoms of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>However, in June 2006, the symptoms worsened to New York Heart Association functional class IV status </plain></SENT>
<SENT sid="4" pm="."><plain>We implanted a continuous-flow left ventricular assist device as a bridge to cardiac transplantation; of note, a left ventricular core biopsy at that time showed no replacement <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The patient's clinical status improved thereafter, enabling left ventricular assist device ex-plantation after 17 months </plain></SENT>
<SENT sid="6" pm="."><plain>To our knowledge, this is the first report of the use of left ventricular assist device support to reverse <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="48120">anthracycline</z:chebi>-induced <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
</text></document>